Cinven invests in Amdipharm
European private equity firm Cinven has acquired the Amdipharm Group, the family-owned international niche pharmaceuticals business, for a total consideration of GBP367m. Amdipharm will operate initially as a standalone business but, over time, Cinven will look to merge Amdipharm with its existing portfolio company, Mercury Pharma, which it acquired in
